PharmaForce Inc., a privately held Columbus, Ohio based pharmaceutical R&D and manufacturing company, was founded in 1999. PharmaForce began as a small team R&D outfit, but quickly expanded to include manufacturing capabilities.
PharmaForce manufactures sterile finished dosage pharmaceutical products in its traditional fill-finish facility located in Hilliard, Ohio, a suburb of Columbus. The facility was commissioned in November 2005. The newest addition to PharmaForce’s facilities as of 2011 is located in New Albany, Ohio. It consists of a state of the art, 109,000 sq. ft. facility which includes 15,000 sq. ft of Research and Development laboratories, 13,000 sq. ft administration area, and a 72,000 sq. ft. Manufacturing Area that is capable of manufacturing highly potent compounds and cytotoxic products.
The plants provide manufacturing support for the commercialization of sterile pharmaceutical products targeted for U.S. markets. The facilities enable PharmaForce to ensure an uninterrupted source of commercial supply while also providing advanced development and clinical manufacturing opportunities. All batches are manufactured in accordance with current Good Manufacturing Practices (cGMPs).
PharmaForce specializes in rapid, high quality sterile drug product development. The Research & Development team is capable of performing a wide range of drug development activities, including formulation development, analytical method development & validation, lyophilization cycle development, process scale-up, technology transfer, stability data generation and NDA/ ANDA document preparation for FDA submission.